Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

News Corp (NWSA): Are Hedge Funds Right About This Stock?

Page 1 of 2

The third-quarter stock market correction has turned out to resemble the situation observed during the Asian financial crisis of 1997. The two relatively short-lived corrections occurred at a time with stable interest rates, falling commodity markets, with strong-performing technology and healthcare sectors, and struggling energy sector. Similarly, the two corrections followed long periods without a correction, which had to come sooner or later and it did. Even so, several prominent hedge fund investors publicly asserted their bearish view on the current state of the U.S. equity markets, suggesting that they significantly cut their exposure to equities during the latest quarter. Having said that, it would be worthwhile to take a look at the hedge fund sentiment on News Corp (NASDAQ:NWSA) in order to identify whether reputable and successful top money managers continue to believe in its potential.

News Corp (NASDAQ:NWSA) has seen a decrease in hedge fund interest lately. At the end of this article we will also compare NWSA to other stocks including AGL Resources Inc. (NYSE:GAS), Gildan Activewear Inc (USA) (NYSE:GIL), and Comerica Incorporated (NYSE:CMA) to get a better sense of its popularity.

Follow Twenty-First Century Fox Inc. (NASDAQ:FOX)
Trade (NASDAQ:FOX) Now!

To most stock holders, hedge funds are viewed as unimportant, outdated investment tools of yesteryear. While there are more than 8000 funds in operation today, We look at the leaders of this group, about 700 funds. It is estimated that this group of investors orchestrate the lion’s share of the smart money’s total asset base, and by observing their top picks, Insider Monkey has formulated several investment strategies that have historically outrun the market. Insider Monkey’s small-cap hedge fund strategy beat the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Keeping this in mind, let’s go over the fresh action regarding News Corp (NASDAQ:NWSA).

What does the smart money think about News Corp (NASDAQ:NWSA)?

At the end of the third quarter, a total of 35 of the hedge funds tracked by Insider Monkey were long this stock, a change of -10% from one quarter earlier. With hedge funds’ capital changing hands, there exists a few noteworthy hedge fund managers who were increasing their stakes considerably (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Pzena Investment Management, managed by Richard S. Pzena, holds the largest position in News Corp (NASDAQ:NWSA). Pzena Investment Management has a $378.5 million position in the stock, comprising 2.4% of its 13F portfolio. The second most bullish fund manager is International Value Advisers, led by Charles de Vaulx, holding a $269.3 million position; 7.2% of its 13F portfolio is allocated to the stock. Some other hedge funds and institutional investors with similar optimism contain Jonathon Jacobson’s Highfields Capital Management, Michael Blitzer’s Kingstown Capital Management and Craig C. Albert’s Sheffield Asset Management.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!